LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Radicicol | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4715 | 4513 | 1.0447 | 1.0615 |
MDA-MB-231 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4659 | 4513 | 1.0323 | 1.0444 |
MDA-MB-231 | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4156 | 4513 | 0.9208 | 0.8910 |
MDA-MB-231 | XL147 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 5018 | 4513 | 1.1119 | 1.1541 |
MDA-MB-231 | Saracatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3593 | 4513 | 0.7961 | 0.7192 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3888 | 4513 | 0.8614 | 0.8091 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3461 | 4513 | 0.7668 | 0.6789 |
MDA-MB-231 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4652 | 4513 | 1.0308 | 1.0424 |
MDA-MB-231 | SU11274 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4689 | 4513 | 1.0389 | 1.0535 |
MDA-MB-231 | Fedratinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4389 | 4513 | 0.9725 | 0.9622 |
MDA-MB-231 | TGX221 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3959 | 4513 | 0.8772 | 0.8309 |
MDA-MB-231 | Torin1 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2359 | 4513 | 0.5226 | 0.3426 |
MDA-MB-231 | Torin2 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1584 | 4513 | 0.3511 | 0.1064 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1382 | 4513 | 0.3063 | 0.0447 |
MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1343 | 4513 | 0.2975 | 0.0327 |
MDA-MB-231 | TWS119 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4320 | 4513 | 0.9573 | 0.9411 |
MDA-MB-231 | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4745 | 4513 | 1.0513 | 1.0707 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4860 | 4513 | 1.0767 | 1.1057 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4613 | 4513 | 1.0221 | 1.0304 |
MDA-MB-231 | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2048 | 4513 | 0.4538 | 0.2479 |
MDA-MB-231 | WZ3105 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 498 | 4513 | 0.1103 | -0.2251 |
MDA-MB-231 | XMD11-50 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3862 | 4513 | 0.8557 | 0.8013 |
MDA-MB-231 | Y39983 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3398 | 4513 | 0.7529 | 0.6597 |
MDA-MB-231 | YM 201636 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4673 | 4513 | 1.0355 | 1.0488 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3680 | 4513 | 0.8155 | 0.7459 |